Selected article for: "current state and knowledge current state"

Author: Christian, Michael D.; Poutanen, Susan M.; Loutfy, Mona R.; Muller, Matthew P.; Low, Donald E.
Title: Severe Acute Respiratory Syndrome
  • Cord-id: kc7msjsz
  • Document date: 2004_5_15
  • ID: kc7msjsz
    Snippet: The first cases of severe acute respiratory syndrome (SARS) occurred in China in November 2002. The agent causing this illness has been identified as a novel coronavirus, SARS-coronavirus. Since its introduction <1 year ago, this virus has infected 8098 people in 26 countries, killing 774 of them. We present an overview of the epidemiology, clinical presentation, diagnosis, and treatment of SARS based on the current state of knowledge derived from published studies and our own personal experienc
    Document: The first cases of severe acute respiratory syndrome (SARS) occurred in China in November 2002. The agent causing this illness has been identified as a novel coronavirus, SARS-coronavirus. Since its introduction <1 year ago, this virus has infected 8098 people in 26 countries, killing 774 of them. We present an overview of the epidemiology, clinical presentation, diagnosis, and treatment of SARS based on the current state of knowledge derived from published studies and our own personal experience.

    Search related documents:
    Co phrase search for related documents
    • accurate estimate and acute ards respiratory distress syndrome: 1
    • accurate test and low sensitivity: 1, 2, 3, 4, 5, 6
    • acute ards respiratory distress syndrome and long term morbidity: 1, 2, 3, 4, 5
    • acute ards respiratory distress syndrome and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35
    • acute ards respiratory distress syndrome and low sensitivity: 1, 2, 3, 4
    • acute ards respiratory distress syndrome and lung damage: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
    • acute ards respiratory distress syndrome and lung protective ventilation strategy: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • acute ards respiratory distress syndrome treatment and lung damage: 1, 2, 3, 4, 5, 6
    • acute ards respiratory distress syndrome treatment and lung protective ventilation strategy: 1
    • acute morbidity and long term morbidity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • acute morbidity and lopinavir ritonavir: 1, 2, 3
    • acute morbidity and lung damage: 1, 2, 3
    • acute morbidity and lung protective ventilation strategy: 1
    • long term morbidity and lung damage: 1, 2
    • lopinavir ritonavir and lung damage: 1, 2, 3, 4, 5, 6
    • lopinavir ritonavir and lung protective ventilation strategy: 1
    • low sensitivity and lung damage: 1, 2